Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II, Multi-Center, Open-Label Trial of PR104 and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer

NCT00862134 is registered in ClinicalTrials.gov with Proacta, Incorporated as lead sponsor.

NCT NCT00862134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00862134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II, Multi-Center, Open-Label Trial of PR104 and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
Lead sponsor
Proacta, Incorporated
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2009
Completion date
May 31, 2010
Enrollment
42 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer